Concord Medical Services Holdings Limited, through its subsidiaries, operates the network of radiotherapy and diagnostic imaging centers in the People’s Republic of China (China or PRC). Network of Centers As of December 31, 2013, the company’s network comprised 144 centers based in 81 hospitals, spanning 55 cities across 25 provinces and administrative regions in China. These hospitals include 3A hospitals. Its network includes 111 radiotherapy and diagnostic imaging centers and 28 centers that provide other treatment and diagnostic services, such as electroencephalography for the diagnosis of epilepsy, thermotherapy to increase the efficacy of and for pain relief after radiotherapy and chemotherapy, high intensity focused ultrasound therapy for the treatment of cancer, stereotactic radiofrequency ablation for the treatment of Parkinson’s Disease and refraction and tonometry for the diagnosis of ophthalmic conditions. Each center is equipped with a primary unit of medical equipment, such as a linear accelerator, head gamma knife system, body gamma knife system, positron emission tomography-computed tomography (PET-CT) scanner, or magnetic resonance imaging (MRI) scanner. Each center is located on the premises of the company’s hospital partners with the facilities of the centers provided by the hospitals. Each center includes a treatment area, a patient preparation and observation room, working areas for the center’s doctors and other personnel and a waiting and reception area. The company provides clinical support services to doctors who work in the centers in its network, which include developing treatment protocols for doctors and organizing joint diagnosis between doctors in its network and clinical research. In addition to its network of centers, the company is in the process of establishing the Beijing Proton Medical Center in Beijing. Service Offerings The principal treatment and diagnostic imaging modalities provided at the company’s centers comprise: Linear Accelerators External Beam Radiotherapy: As of December 31, 2013, the company owned 30 linear accelerators and 1 MM50 intensity-modulated radiation therapy systems. Linear accelerators use microwave technology to deliver a high-energy X-ray beam directed at the tumor. Linear accelerators could be used to treat tumors in the brain or elsewhere in the body. Gamma Knife Radiosurgery: A gamma knife is used in radiosurgery for the treatment of tumors and other abnormal growths. The company’s network of centers operates two types of gamma knife systems, such as head gamma knife systems and body gamma knife systems. As of December 31, 2013, the company owned 38 gamma knife systems, including 23 head gamma knife systems and 15 body gamma knife systems. Head Gamma Knife Systems: Head gamma knife systems are primarily used for the treatment of brain tumors. Head gamma knife systems could also be used to treat other conditions, such as certain types of brain lesions, trigeminal neuralgia (facial pain), and arteriovenous malformations (abnormal connection between veins and arteries). Body Gamma Knife Systems: Body gamma knife systems are used for the treatment of tumors located in the body and outside of the brain. Cyberknife: The CyberKnife Robotic Radiosurgery System is a non-invasive alternative to surgery for the treatment of both cancerous and non-cancerous tumors anywhere in the body, including the prostate, lung, brain, spine, liver, pancreas, and kidney. As of December 31, 2013, the company had two Cyber-knife centers in China. Its first CyberKnife Robotic Radiosurgery System is located in Changhai Hospital, which has treated approximately 1,551 patients. Its second Cyber-knife center is in Jinan City of Shandong Province. Proton Beam Therapy: Proton beam therapy is a form of external beam radiotherapy that uses beams of protons rather than the X-ray beams used by linear accelerators. Diagnostic Imaging: The company’s network of centers employs a range of diagnostic imaging equipment. Such equipment includes various advanced diagnostic imaging technology available in China, including PET-CT scanners. As of December 31, 2013, the company owned 19 PET-CT scanners and 25 MRI scanners. Hospital Business The company owns 52% equity ownership in Chang’an Hospital Co., Ltd. (Chang’an Hospital), a non-public general hospital located in Xi’an, Shaanxi Province. Chang’an Hospital is an international general hospital integrating clinical care, healthcare, preventative care and research. Subsidiaries Shenzhen Aohua Medical Technology & Services Co., Ltd., the company’s wholly owned subsidiary, is engaged in the provision of radiotherapy and diagnostic equipment leasing services to hospitals in the PRC. Medstar (Shanghai) Leasing Co., Ltd., the company’s wholly owned subsidiary, is engaged in the sale of medical equipment and the provision of radiotherapy and diagnostic equipment leasing and management services to hospitals in the PRC. CMS Hospital Management Co., Ltd., the company’s wholly owned subsidiary, is engaged in the provision of radiotherapy and diagnostic equipment management services to hospitals in the PRC. Beijing Yundu Internet Technology Co., Ltd., the company’s wholly owned subsidiary, is engaged in the provision of radiotherapy and diagnostic equipment management services to hospitals in the PRC. Chang’an CMS International Cancer Center, which specializes in cancer diagnosis and treatment in Xi’An, is established by the company and Chang’an Hospital. Tianjing Kangmeng Radiology Equipment Management Co., Ltd, the company’s wholly owned subsidiary, manages four radiotherapy and diagnostic imaging centers in Hebei province. Acquisitions In 2013, the company closed the acquisition of 19.98% of indirect ownership of The University of Texas MD Anderson Cancer Center Proton Therapy Center. Competition The company’s competitors include China Renji Medical Group Ltd. and Jiancheng Investment Co. History Concord Medical Services Holdings Limited was founded in 1996.
concord medical - spon adr
Tower A, Global Trade Center
36 North Third Ring Road East
Phone: 86 10 5903 6688
Fax: 86 10 5957 5252www.cmsholdings.com
|China Renji Medical Group Ltd/Hong Kong||$0.34 HKD||+0.005|
|View Industry Companies|
Sponsored Financial Commentaries
To contact CONCORD MEDICAL - SPON ADR, please visit www.cmsholdings.com. Company data is provided by Capital IQ. Please use this form to report any data issues.